Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Iceland launches massive screening study to detect cancer risk before it starts

NCT ID NCT03327597

First seen Sep 30, 2025 · Last updated May 20, 2026 · Updated 25 times

Summary

This study is testing whether screening healthy people for a condition called MGUS can help find multiple myeloma earlier. Over 80,000 adults in Iceland were invited to participate. The goal is to see if early detection leads to better survival and fewer complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Iceland

    Reykjavik, Iceland

Conditions

Explore the condition pages connected to this study.